AnaptysBio News

AnaptysBio | 8-K: Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update

May 9 16:53 ET

AnaptysBio | DEF 14A: Definitive information statements

Apr 24 16:11 ET

AnaptysBio | DEFA14A: Others

Apr 24 16:10 ET

AnaptysBio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 11 16:43 ET

AnaptysBio | 8-K: Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 11 16:25 ET

AnaptysBio | 8-K: Current report

Jan 5 00:00 ET

AnaptysBio | 8-K: Current report

Nov 27, 2023 16:17 ET

AnaptysBio | 8-K: Anaptys Announces Third Quarter 2023 Financial Results and Provides Business Update

Nov 2, 2023 16:18 ET

AnaptysBio | 8-K: Current report

Oct 25, 2023 16:43 ET

AnaptysBio | 8-K: Current report

Oct 10, 2023 09:01 ET

AnaptysBio | 8-K: Current report

Sep 18, 2023 16:18 ET

AnaptysBio | 8-K: AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update

Aug 7, 2023 16:18 ET

AnaptysBio | 8-K: Current report

Jun 15, 2023 17:15 ET

AnaptysBio | 8-K: AnaptysBio Announces First Quarter 2023 Financial Results and Provides Pipeline Update

May 11, 2023 16:17 ET

AnaptysBio | DEFA14A: Others

Apr 27, 2023 16:12 ET

AnaptysBio | DEF 14A: Definitive proxy statements

Apr 27, 2023 16:05 ET

AnaptysBio | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 14, 2023 16:15 ET

AnaptysBio | 8-K: Current report

Apr 6, 2023 16:18 ET

AnaptysBio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 1, 2023 16:16 ET

AnaptysBio | 8-K: AnaptysBio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Mar 1, 2023 16:09 ET